Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trial
Xiumin Yang, Chao Ji, Yuling Shi, Jinhua Xu et al.
Journal
Chinese Medical Journal
Topics
Psoriasis: Treatment and Pathogenesis
article
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trial
Xiumin Yang, Chao Ji, Yuling Shi, Jinhua Xu, Kun Huang, Zhenying Zhang, Yan Lü, Bin Yang, Xiaohua Tao, Juan Tao, Rong Xiao, Wei Yan, Qianjin Lu, Shuzheng Lyu, Furen Zhang, Min Zheng, Songmei Geng, Yuhan Huang, Liangdan Sun, Lu Wang, Ming Chen, Rui Wang, Chunlei Zhang, Juan Su, Hao Cheng, Zhiming Li, Jie Zheng, Zhiqiang Song, Litao Zhang, Tong Zhang, Huiping Wang, Weilong Zhao, Shoumin Zhang, Zhongqi Dong
article en
Abstract
No abstract available for this paper.
Publication Tag
Chinese Medical Journal
Institutions
Tianjin University of Traditional Chinese Medicine (CN), Beijing Tongren Hospital (CN), Fujian Medical University (CN), Southwest General Health Center (US), Johnson & Johnson (United States) (US), Central South University (CN), Capital Medical University (CN), Anhui Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Sichuan University (CN), Fudan University (CN), Wenzhou Medical University (CN), Ruijin Hospital (CN), First Affiliated Hospital of Wenzhou Medical University (CN), Sir Run Run Shaw Hospital (CN), Tianjin Medical University General Hospital (CN), West China Hospital of Sichuan University (CN), Second Hospital of Shandong University (CN), Chinese Academy of Medical Sciences Dermatology Hospital (CN), First Affiliated Hospital of Fujian Medical University (CN), Wuhan Union Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Zhejiang Provincial People's Hospital (CN), Southwest Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Henan Provincial People's Hospital (CN), Johnson & Johnson (Israel) (IL), First Affiliated Hospital of Anhui Medical University (CN), Johnson & Johnson (United Kingdom) (GB), University of Hong Kong - Shenzhen Hospital (CN), Peking University Third Hospital (CN), Second Affiliated Hospital of Anhui Medical University (CN), Second Xiangya Hospital of Central South University (CN), Shanghai Skin Disease Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Huashan Hospital (CN), Xiangya Hospital Central South University (CN), Jiangsu Provincial Hospital of Traditional Chinese Medicine (CN), Union Hospital (CN), Southern Medical University (CN), Zhejiang University (CN), Chongqing Medical University (CN), University of Hong Kong (HK)